한글목차

MRD 검사 동향 및 예측

세계 MRD 검사 시장은 2024년부터 2030년까지 복합 연간 성장률(CAGR) 12.8%를 나타낼 전망이며, 2030년까지 44억 달러에 이를 것으로 예상됩니다. 이 시장의 주요 촉진 요인은 혈액 관련 암 증가, 세계 노인 인구 증가, 미세 잔류 병변(MRD) 검사 기술의 진보입니다. 세계 MRD 검사 시장의 미래는 병원과 전문 클리닉, 진단 실험실, 학술 및 연구 기관 시장의 비즈니스 기회로 유망시되고 있습니다.

MRD 검사 시장 인사이트

Lucintel은 중합효소 연쇄반응(PCR) 예측 기간 동안 가장 높은 성장을 이룰 것으로 예측됩니다.

이 시장에서 병원과 전문 클리닉은 가장 큰 부문이 될 것입니다.

아시아태평양은 예측 기간 동안 가장 높은 성장이 예상됩니다.

이 보고서는 다음 11가지 주요 질문에 답변합니다.

• Q.1. 시장 부문 중 가장 유망하고 고성장하는 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장하는지, 그리고 그 이유는?
• Q.3. 앞으로 성장이 가속될 것으로 보이는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은?
• Q.6. 이 시장에서의 새로운 동향과 그 이유는?
• Q.7. 시장에서 고객 수요 변화에는 어떤 것이 있는가?
• Q.8. 이 시장에서의 새로운 개발과 그 개발을 리드하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 노력을 추진하고 있는가?
• Q.10. 이 시장에서 경쟁 제품은 어떠한 것이며, 재료 및 제품의 대체로 인한 시장 점유율 저하의 위협은 어느 정도입니까?
• Q.11. 지난 5년 동안 어떤 M&D가 수행되었고 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 MRD 검사 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진 요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 MRD 검사 시장 동향(2018-2023년)과 예측(2024-2030년)
• 기술별 세계의 MRD 검사 시장
  • 플로우 사이토메트리
  • 중합효소 연쇄반응(PCR)
  • 차세대 시퀀싱(NGS)
  • 기타
• 용도별 세계의 MRD 검사 시장
  • 혈액 악성 종양
  • 백혈병
  • 림프종
  • 고형 종양
  • 기타
• 최종 이용 산업별 세계의 MRD 검사 시장
  • 병원과 전문 클리닉
  • 진단 실험실
  • 학술연구기관
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 MRD 검사 시장
• 북미의 MRD 검사 시장
• 유럽의 MRD 검사 시장
• 아시아태평양 MRD 검사 시장
• 기타 지역 MRD 검사 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 기술별 세계의 MRD 검사 시장의 성장 기회
  • 용도별 세계의 MRD 검사 시장의 성장 기회
  • 최종 이용 산업별 세계의 MRD 검사 시장의 성장 기회
  • 지역별 세계의 MRD 검사 시장의 성장 기회
• 세계의 MRD 검사 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계 MRD 검사 시장의 능력 확대
  • 세계의 MRD 검사 시장에서의 합병, 인수, 합작 사업
  • 인증 및 라이선스

제7장 유력 기업의 기업 프로파일

• Labcorp
• F. Hoffmann-La Roche
• Guardant Health
• Sysmex Corporation
• NeoGenomics Laboratories
• Adaptive Biotechnologies Corporation
• ArcherDX
• Asuragen
• Arup Laboratories

영문목차

MRD Testing Trends and Forecast

The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $4.4 billion by 2030 with a CAGR of 12.8% from 2024 to 2030. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.

A more than 150-page report is developed to help in your business decisions.

MRD Testing by Segment

The study includes a forecast for the global MRD testing by technology, application, end use industry, and region.

MRD Testing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Flow Cytometry
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• Others

MRD Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Hematological Malignancies
• Leukemia
• Lymphoma
• Solid Tumors
• Others

MRD Testing Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals and Specialty Clinics
• Diagnostic Laboratories
• Academic & Research Institutes
• Others

MRD Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of MRD Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies MRD testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the MRD testing companies profiled in this report include-

• Labcorp
• F. Hoffmann-La Roche
• Guardant Health
• Sysmex Corporation
• Neogenomics Laboratories
• Adaptive Biotechnologies Corporation
• Archerdx
• Asuragen
• Arup Laboratories

MRD Testing Market Insights

Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.

Within this market, hospitals and specialty clinics will remain the largest segment.

APAC is expected to witness highest growth over the forecast period.

Features of the Global MRD Testing Market

Market Size Estimates: MRD testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: MRD testing market size by various segments, such as by application, end use industry, and region. in terms of value ($B).

Regional Analysis: MRD testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, applications, end use industries, and region.s for the MRD testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the MRD testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the MRD testing market size?

Answer: The global MRD testing market is expected to reach an estimated $4.4 billion by 2030.

Q.2. What is the growth forecast for MRD testing market?

Answer: The global MRD testing market is expected to grow with a CAGR of 12.8% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the MRD testing market?

Answer: The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.

Q.4. What are the major segments for MRD testing market?

Answer: The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets.

Q.5. Who are the key MRD testing market companies?

Answer: Some of the key MRD testing companies are as follows:

• Labcorp
• F. Hoffmann-La Roche
• Guardant Health
• Sysmex Corporation
• NeoGenomics Laboratories
• Adaptive Biotechnologies Corporation
• ArcherDX
• Asuragen
• Arup Laboratories

Q.6. Which MRD testing market segment will be the largest in future?

Answer: Lucintel forecasts that next-generation sequencing (NGS) is expected to witness highest growth over the forecast period.

Q.7. In MRD testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the MRD testing market by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global MRD Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global MRD Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global MRD Testing Market by Technology
  • 3.3.1: Flow Cytometry
  • 3.3.2: Polymerase Chain Reaction (PCR)
  • 3.3.3: Next-Generation Sequencing (NGS)
  • 3.3.4: Others
• 3.4: Global MRD Testing Market by Application
  • 3.4.1: Hematological Malignancies
  • 3.4.2: Leukemia
  • 3.4.3: Lymphoma
  • 3.4.4: Solid Tumors
  • 3.4.5: Others
• 3.5: Global MRD Testing Market by End Use Industry
  • 3.5.1: Hospitals and Specialty Clinics
  • 3.5.2: Diagnostic Laboratories
  • 3.5.3: Academic & Research Institutes
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global MRD Testing Market by Region
• 4.2: North American MRD Testing Market
  • 4.2.2: North American MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
• 4.3: European MRD Testing Market
  • 4.3.1: European MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
  • 4.3.2: European MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
• 4.4: APAC MRD Testing Market
  • 4.4.1: APAC MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
  • 4.4.2: APAC MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
• 4.5: ROW MRD Testing Market
  • 4.5.1: ROW MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
  • 4.5.2: ROW MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global MRD Testing Market by Technology
  • 6.1.2: Growth Opportunities for the Global MRD Testing Market by Application
  • 6.1.3: Growth Opportunities for the Global MRD Testing Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global MRD Testing Market by Region
• 6.2: Emerging Trends in the Global MRD Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global MRD Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global MRD Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Labcorp
• 7.2: F. Hoffmann-La Roche
• 7.3: Guardant Health
• 7.4: Sysmex Corporation
• 7.5: NeoGenomics Laboratories
• 7.6: Adaptive Biotechnologies Corporation
• 7.7: ArcherDX
• 7.8: Asuragen
• 7.9: Arup Laboratories